Hyperkalemia Quality Improvement Program (HK-QIP) study

Trial Identifier:	D9480L00029
Sponsor:	AstraZeneca
Start Date:	June 2025
Primary Completion Date:	November 2027
Study Completion Date:	November 2027
Condition:	Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
CN	Shanghai, CN, 200032
CN	Shanghai, CN, 200233

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.